Catalyst Funds Management’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-900
Closed -$33.3K 1344
2024
Q2
$33.3K Buy
+900
New +$33.3K 0.01% 529